The protein’s potential as a potent vaccine antigen in L. donovani has been evaluated by Sabur et al.55 who generated liposomal forms of leishmanial elongation factor 1 vaccine and both the recombinant and truncated vaccine provided long term immunity in BALB/c mice against visceral leishmaniasis. This evidence concerns the gene ELOF1 and visceral leishmaniasis.